Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGINTERVENTIONAL

Adapting the FACETS Program to Sickle Cell Disease

Adapting the FACETS Fatigue Management Program to Sickle Cell Disease

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

Adaptation of a fatigue management program combining the principles of cognitive-behavioral therapy and energy conservation strategies (FACETS program) for a population of adult patients with sickle cell disease (Drépa-FACETS program).

Who May Be Eligible (Plain English)

Who May Qualify: - Participant having freely given his oral agreement. - Participant with a major sickle cell syndrome, regardless of genotype (e.g. SS, SC, Sbeta). - Participant with a sufficient command of spoken and written French to take the assessments, complete the questionnaires, follow the program sessions and carry out the home exercises. Who Should NOT Join This Trial: - Participant with one or more severe psychiatric pathologies (e.g. severe depression, psychosis) that could interfere with the conduct of the study, in particular the primary and secondary endpoints. - Participants with another chronic pathology causing fatigue. - Participants in vaso-occlusive crisis (VOC) or hospitalization. - Participant under legal protection (guardianship, curatorship, safeguard of justice, deprived of liberty). Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Participant having freely given his oral agreement. * Participant with a major sickle cell syndrome, regardless of genotype (e.g. SS, SC, Sbeta). * Participant with a sufficient command of spoken and written French to take the assessments, complete the questionnaires, follow the program sessions and carry out the home exercises. Exclusion Criteria: * Participant with one or more severe psychiatric pathologies (e.g. severe depression, psychosis) that could interfere with the conduct of the study, in particular the primary and secondary endpoints. * Participants with another chronic pathology causing fatigue. * Participants in vaso-occlusive crisis (VOC) or hospitalization. * Participant under legal protection (guardianship, curatorship, safeguard of justice, deprived of liberty).

Treatments Being Tested

OTHER

Drépa-FACETS Program

Drépa-FACETS Program for Sickle Cell Disease

Locations (2)

CHU Grenoble Alpes
Grenoble, France
Hospital Versailles
Le Chesnay, France